Jpmorgan Chase & CO Moderna, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Moderna, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,227,044 shares of MRNA stock, worth $85.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,227,044

Previous 1,756,708 26.77%

Holding current value

$85.4 Million

Previous $209 Million 28.65%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$63.64 - $125.14 $29.9 Million - $58.9 Million	470,336 Added 26.77%	2,227,044 $149 Million
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $31.9 Million - $52.5 Million	315,268 Added 21.87%	1,756,708 $209 Million
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $92.8 Million - $126 Million	-1,087,231 Reduced 43.0%	1,441,440 $154 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $3.68 Million - $5.52 Million	-52,885 Reduced 2.05%	2,528,671 $251 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $16 Million - $21 Million	166,182 Added 6.88%	2,581,556 $267 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $63 Million - $85.4 Million	531,790 Added 28.23%	2,415,374 $293 Million
Q1 2023 May 18, 2023	BUY	$135.66 - $197.02 $21.1 Million - $30.6 Million	155,510 Added 9.0%	1,883,584 $289 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $127 Million - $184 Million	933,493 Added 117.48%	1,728,074 $265 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $12.2 Million - $21.6 Million	103,009 Added 14.89%	794,581 $143 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $52.8 Million - $86.8 Million	-446,785 Reduced 39.25%	691,572 $81.8 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $8.81 Million - $13.3 Million	75,202 Added 7.07%	1,138,357 $163 Million
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $697,300 - $1.3 Million	-5,514 Reduced 0.52%	1,063,155 $183 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $47.2 Million - $77 Million	-209,082 Reduced 16.36%	1,068,669 $271 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $284 Million - $619 Million	1,277,751 New	1,277,751 $492 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Moderna, Inc. Transaction History